Nurix Therapeutics
NRIX
12.85
-0.75
-5.51%
Nurix Therapeutics
US · NRIX
#2679 by market cap
Listed 2020
12.85
-0.75
-5.51%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
RBC Capital Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36Market Newswire · 2026/8/10
-
Rating change
Wells Fargo Maintains Nurix Therapeutics(NRIX.US) With Hold Rating, Maintains Target Price $25Market Newswire · 2026/7/14
-
Rating change
Baird Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $36Market Newswire · 2026/10/13
-
Rating change
Oppenheimer Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $32Market Newswire · 2026/10/13
-
Rating change
Oppenheimer Initiates Nurix Therapeutics(NRIX.US) With Buy Rating, Announces Target Price $28Market Newswire · 2026/6/29
-
Piper Sandler Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $35Market Newswire · 2026/11/2
-
Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $41Market Newswire · 2026/11/5
-
Rating change
Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $38Market Newswire · 2026/7/28
-
Rating change
H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $36Market Newswire · 2026/10/16
-
Rating change
A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $32 to $41Market Newswire · 2026/10/13
-
Rating change
Morgan Stanley Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $38Market Newswire · 2026/10/15
-
Rating change
Mizuho Securities Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $34Market Newswire · 2026/7/13
-
Rating change
UBS Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Raises Target Price to $31Market Newswire · 2026/7/22
-
Rating change
Jefferies Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $45Market Newswire · 2026/7/8
-
Rating change
Needham Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34Market Newswire · 2026/8/4
-
H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $36Market Newswire · 2026/11/5
-
Rating change
Truist Financial Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Cuts Target Price to $33Market Newswire · 2026/10/13
-
BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/11/4
-
Rating change
A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $28 to $40Market Newswire · 2026/7/11
-
Following Cathie Wood’s strategy: increase holdings in NRIX and SPCX, and reduce positions in PSNL and BLSH.牛牛名人追蹤 · 2026/11/5
-
Rating change
H.C. Wainwright Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/6/11
-
Rating change
J.P. Morgan Maintains Nurix Therapeutics(NRIX.US) With Buy RatingMarket Newswire · 2026/6/12
-
Rating change
Stifel Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $34Market Newswire · 2026/6/15
-
Rating change
BTIG Maintains Nurix Therapeutics(NRIX.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/7/1
-
Rating change
A Quick Look at Today's Ratings for Nurix Therapeutics(NRIX.US), With a Forecast Between $25 to $32Market Newswire · 2026/6/10
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Nurix Therapeutics discussion 0 comments